Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Medicamen Biotech Ltd.

May 18, 04:01 BSE 536.95 (+ 6.50 1.23%)

Volume275

Prev. Close
530.45

Open Price
537.95

Today's Low / High

532.55 539.90

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

356.75 903.50

May 18, 12:40 NSE 536.10(+ 6.60 1.25%)

Volume4435

Prev. Close
529.50

Open Price
544.90

Today's Low / High

530.55 555.00

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

355.45 845.00

(₹ in Crs.)

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	140.41	108.29	110.72	123.62	121.23
Other Operating Revenues	0.46	7.15	1.99	1.88	1.37
Total Operating Revenues	140.87	115.45	112.72	125.50	122.60

Other Income	2.46	1.72	0.75	1.94	3.66
Total Revenue	143.33	117.17	113.47	127.44	126.26

EXPENSES
Cost Of Materials Consumed	81.80	55.69	68.42	80.45	79.74
Purchase Of Stock-In Trade	0.00	0.00	0.00	0.00	2.21
Operating And Direct Expenses	13.90	15.10	9.74	11.55	0.02
Changes In Inventories Of FG,WIP And Stock-In Trade	-9.71	-3.34	1.04	-1.53	1.39
Employee Benefit Expenses	20.44	14.50	9.00	9.52	8.09
Finance Costs	2.92	1.40	1.06	0.57	0.94
Depreciation And Amortisation Expenses	6.37	5.77	2.52	2.50	2.21
Other Expenses	10.56	9.94	5.29	6.40	14.14
Total Expenses	126.28	99.07	97.08	109.46	108.74

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	17.05	18.09	16.39	17.98	17.52

Profit/Loss Before Tax	17.05	18.09	16.39	17.98	17.52

Tax Expenses-Continued Operations
Current Tax	3.70	3.98	4.15	4.94	5.50
Deferred Tax	-1.38	-0.78	0.12	-0.25	0.00
Total Tax Expenses	2.32	3.20	4.26	4.69	5.50
Profit/Loss After Tax And Before ExtraOrdinary Items	14.73	14.90	12.13	13.29	12.03

Profit/Loss From Continuing Operations	14.73	14.90	12.13	13.29	12.03

Profit/Loss For The Period	14.73	14.90	12.13	13.29	12.03

Minority Interest	0.12	0.00	0.00	0.00	0.00
Consolidated Profit/Loss After MI And Associates	14.84	14.90	12.13	13.29	12.03

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	11.92	12.19	9.93	10.94	10.28
Diluted EPS (Rs.)	11.92	12.19	9.93	10.94	10.28

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	1.27	1.22	0.00	0.00	0.00

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	140.41
Other Operating Revenues	0.46
Total Operating Revenues	140.87
Other Income	2.46
Total Revenue	143.33
EXPENSES
Cost Of Materials Consumed	81.80
Purchase Of Stock-In Trade	0.00
Operating And Direct Expenses	13.90
Changes In Inventories Of FG,WIP And Stock-In Trade	-9.71
Employee Benefit Expenses	20.44
Finance Costs	2.92
Depreciation And Amortisation Expenses	6.37
Other Expenses	10.56
Total Expenses	126.28
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	17.05
Profit/Loss Before Tax	17.05
Tax Expenses-Continued Operations
Current Tax	3.70
Deferred Tax	-1.38
Total Tax Expenses	2.32
Profit/Loss After Tax And Before ExtraOrdinary Items	14.73
Profit/Loss From Continuing Operations	14.73
Profit/Loss For The Period	14.73
Minority Interest	0.12
Consolidated Profit/Loss After MI And Associates	14.84
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	11.92
Diluted EPS (Rs.)	11.92
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	1.27